Plexus Corp. (NASDAQ:PLXS) Director Randy J. Martinez Sells 887 Shares

Plexus Corp. (NASDAQ:PLXSGet Free Report) Director Randy J. Martinez sold 887 shares of the stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $140.52, for a total transaction of $124,641.24. Following the completion of the sale, the director now directly owns 4,831 shares in the company, valued at $678,852.12. This trade represents a 15.51 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Plexus Stock Down 1.7 %

Shares of NASDAQ PLXS opened at $137.34 on Friday. The stock has a 50 day moving average price of $153.12 and a 200 day moving average price of $144.86. The firm has a market capitalization of $3.71 billion, a price-to-earnings ratio of 31.87 and a beta of 0.89. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $172.89. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53.

Plexus (NASDAQ:PLXSGet Free Report) last posted its quarterly earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. Sell-side analysts expect that Plexus Corp. will post 5.9 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Stifel Nicolaus began coverage on Plexus in a research note on Tuesday, February 4th. They set a “hold” rating and a $152.00 target price on the stock. Needham & Company LLC upped their price objective on Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Benchmark reiterated a “buy” rating and set a $165.00 target price on shares of Plexus in a research report on Wednesday, January 22nd. Finally, StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $163.00.

Read Our Latest Analysis on PLXS

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Blue Trust Inc. lifted its position in shares of Plexus by 12.1% in the 4th quarter. Blue Trust Inc. now owns 776 shares of the technology company’s stock worth $121,000 after purchasing an additional 84 shares during the period. Nomura Asset Management Co. Ltd. lifted its holdings in Plexus by 45.5% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company’s stock worth $50,000 after buying an additional 100 shares during the period. Glenmede Trust Co. NA lifted its holdings in Plexus by 4.4% during the third quarter. Glenmede Trust Co. NA now owns 2,453 shares of the technology company’s stock worth $335,000 after buying an additional 104 shares during the period. Tocqueville Asset Management L.P. boosted its position in Plexus by 1.8% during the 4th quarter. Tocqueville Asset Management L.P. now owns 5,907 shares of the technology company’s stock valued at $924,000 after acquiring an additional 107 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Plexus by 17.2% in the 4th quarter. GAMMA Investing LLC now owns 891 shares of the technology company’s stock valued at $139,000 after acquiring an additional 131 shares during the period. Hedge funds and other institutional investors own 94.45% of the company’s stock.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.